Patent ID: 11865089
Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 0:
1. An aqueous ready to infuse stable parenteral dosage form consisting essentially of:
a. norepinephrine or its pharmaceutically acceptable salt at a concentration ranging from to 75 micrograms/ml of norepinephrine base;
b. at least one sulfite antioxidant; and
c. at least one ion chelator,, wherein, after subjected to terminal sterilization by autoclaving and stored at 40° C. and 25% relative humidity for 6 months, the dosage form contains no more than 0.2% by weight of each of 1,2,3,4-tetrahydroisoquinoline-4,6,7-triol, 1,2,3,4-tetrahydroisoquinoline-4,7,8-triol, and 3,4-dihydroxybenzaldehyde.